Glenmark's psoriasis spray gets US approval

摘要

Glenmark Pharmaceuticals said it has received final nod from US health regulator for its Clobeta-sol Propionate spray used for treatment of moderate to severe plaque psoriasis in adults. Glenmark Pharmaceuticals Inc, USA has received final approval from the United States Food & Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 per cent, the company said in a statement.